Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03665597
Brief Title: Relative Bioavailability Study of Subcutaneous Injection Versus Intravenous Infusion of Pembrolizumab (MK-3475) in Participants With Advanced Melanoma (MK-3475-555/KEYNOTE-555)

First Submitted : August 23, 2018
First Submitted that Met QC Criteria : September 7, 2018
First Posted : September 11, 2018

Last Update Submitted that Met QC Criteria : September 4, 2019
Last Update Posted : September 5, 2019 (Estimate)